Nothing shows the inability to argue the facts more than ad-hominem attacks against doctors. It it particularly ironic that liberals who are supposedly very sensitive to the different experiences and beliefs of diverse cultures are immediately ready to ridicule an African woman doctor based on her ability to provide culturally sensitive messages to other people with similar cultural backgrounds.
It appears that leftist beliefs are paramount, and ridiculing a successful, extremely educated African woman is acceptable when she disagrees with leftist orthodoxy.
Actually, free, Dr. Risch’s peer-reviewed scientific paper on it was published on May 27, 2020, in the American Journal of Epidemiology, Oxford University Press. Dr. Risch has over 300 peer-reviewed journal articles published. He’s no lightweight "kook."
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic CrisisHarvey A Risch
American Journal of Epidemiology, kwaa093,
Paper Source, Oxford University Press
Published: 27 May 2020Abstract More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality. An outpatient treatment that prevents hospitalization is desperately needed. Two candidate medications have been widely discussed: remdesivir, and hydroxychloroquine+azithromycin. Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials have been registered in outpatients. Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September. Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease. Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users, of which estimated mortality is <20%, 9/100,000 users, compared to the 10,000 Americans now dying each week. These medications need to be widely available and promoted immediately for physicians to prescribe.
Azithromycin, Covid-19, Doxycycline, Hydroxychloroquine, Remdesivir, SARS-CoV-2, Zinc
Topic: cardiac arrhythmia doxycycline azithromycin hydroxychloroquine ambulatory care services inpatients outpatients terminally ill antibodies mortality zinc older adult pandemics standard of care remdesivir sars-cov-2 covid-19
Issue Section: Special article